4
MARKET OVERVIEW
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNTIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
This section summarizes market dynamics, key shifts, and high-impact trends shaping demand outlook.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN THE PROTEOMICS SERVICE MARKET
5.5.1
IMPORT SCENARIO (HS CODE 902720 AND 902781)
5.5.2
EXPORT SCENARIO (HS CODE 902720 AND 902781)
5.6
KEY CONFERENCES AND EVENTS, 2025–2026
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8
INVESTMENT AND FUNDING SCENARIO
5.8.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.9
IMPACT OF 2025 US TARIFF – PROTEOMICS SERVICES MARKET
5.9.3
PRICE IMPACT ANALYSIS
5.9.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.3
PROTEIN MICROARRAYS
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
ADJACENT TECHNOLOGIES
6.3.1
SINGLE CELL PROTEOMICS
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON PROTEOMICS SERVICES MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN THE PROTEOMICS SERVICES MARKET
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE PROTEOMICS SERVICES MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
PROTEOMICS SERVICES MARKET, BY SERVICE TYPE, 2023-2030 (USD MILLION)
COMPARATIVE ASSESSMENT OF KEY TYPES, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
9.2
CORE PROTEOMICS SERVICES
9.2.1
PROTEIN IDENTIFICATION SERVICES
9.2.2
QUANTITATIVE PROTEOMICS SERVICES
9.2.3
PROTEIN CHARACTERIZATION SERVICES
9.2.4
PROTEIN PURIFICATION SERVICES
9.2.5
PROTEIN SEPARATION SERVICES
9.2.6
PROTEIN SEQUENCING SERVICES
9.2.7
CUSTOM ASSAY SERVICES
9.3
BIOINFORMATICS SERVICES
10
PROTEOMICS SERVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
10.2
CLINICAL DIAGNOSTICS
10.2.2
INFECTIOUS DISEASES
10.2.4
NEUROLOGICAL DISORDERS
10.2.5
AUTOIMMUNE DISEASES
10.2.6
CARDIOVASCULAR DISEASES
10.2.7
OTHER CLINICAL DIAGNOSTIC APPLICATIONS
10.3
DRUG DISCOVERY & DEVELOPMENT
10.3.2
LEAD IDENTIFICATION
10.3.4
PRECLINICAL STUDIES
11
PROTEOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
11.2
BIOPHARMACEUTICAL COMPANIES
11.3
ACADEMIC & RESEARCH INSTITUTES
11.5
CLINICAL LABORATORIES
12
PROTEOMICS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
ASSESSMENT OF GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY GEOGRAPHIES AND COUNTRIES
12.2.3
MACROECONOMIC OUTLOOK OF NORTH AMERICA
12.3.8
MACROECONOMIC OUTLOOK OF EUROPE
12.4.6
REST OF ASIA PACIFIC
12.4.7
MACROECONOMIC OUTLOOK OF ASIA PACIFIC
12.5.3
REST OF LATIN AMERICA
12.5.4
MACROECONOMIC OUTLOOK OF LATIN AMERICA
12.6.2
REST OF MIDDLE EAST
12.6.3
MACROECONOMIC OUTLOOK OF MIDDLE EAST
12.7.1
MACROECONOMIC OUTLOOK OF AFRICA
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
13.2
KEY PLAYERS STRATEGY/ RIGHT TO WIN
13.3
REVENUE ANALYSIS, 2022-2024
13.4
MARKET SHARE ANALYSIS,
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
13.5.5.1
COMPANY FOOTPRINT
13.5.5.2
REGION FOOTPRINT
13.5.5.3
PRODUCT FOOTPRINT
13.5.5.4
TECHNIQUE FOOTPRINT
13.5.5.5
APPLICATION FOOTPRINT
13.6
COMPANY EVALUATION MATRIX: START-UPS/SMES,
13.6.1
PROGRESSIVE COMPANIES
13.6.2
RESPONSIVE COMPANIES
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
13.7
COMPETITIVE SCENARIO
13.7.3
OTHER DEVELOPMENTS
13.8
BRAND/ PRODUCT COMPARATIVE ANALYSIS
13.9
VALUATION AND FINANCIAL METRICS
14.1.1
THERMO FISHER SCIENTIFIC INC (US)
14.1.2
DANAHER CORPORATION (US)
14.1.3
AGILENT TECHNOLOGIES (US)
14.1.6
EUROFINS SCIENTIFIC. (LUXEMBOURG)
14.1.7
CHARLES RIVER LABORATORIES (US)
14.1.8
PROTAGENE (GERMANY)
15.1.1.1
KEY SOURCES OF SECONDARY DATA
15.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
15.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
15.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
15.2
MARKET SIZE ESTIMATION
15.2.1
PROTEOMICS SERVICES MARKET SIZE ESTIMATION
15.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
15.2.1.2
MNM REPOSITORY ANALYSIS
15.2.1.3
SECONDARY ANALYSIS
15.2.1.4
PRIMARY RESEARCH
15.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
15.3
MARKET GROWTH RATE PROJECTIONS
15.6
RESEARCH ASSUMPTIONS
15.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
16.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
AVAILABLE CUSTOMIZATIONS
Growth opportunities and latent adjacency in Proteomics Services Market